Skip to main content
Clinical Trials/NCT01890499
NCT01890499CompletedNot Applicable

PROSPECTIVE RANDOMIZED CONTROLLED TRIAL ON CLEAR FEEDS VERSUS LOW RESIDUE DIET AFTER SURGERY IN ELECTIVE COLORECTAL SURGERY PATIENTS.

Cedars-Sinai Medical Center1 site in 1 country104 target enrollmentStarted: November 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
104
Locations
1
Primary Endpoint
Development of nausea and vomiting on postoperative day two

Study Overview

Brief Summary

Prospective randomized controlled trial investigating commencement of low residue diet versus clear feeds on postoperative day one following elective colorectal surgery, with regards to patient tolerability, incidence of nausea and/or vomiting, and postoperative length of hospitalization stay.

Detailed Description

Based on current literature, the incidence of postoperative nausea and vomiting varies widely and can reach up to 40% in abdominal surgery patients. Thus, patient tolerability to postoperative enteral feeds is taken as 60%. This is a superiority trial: group one is the clear feeds group and patient tolerability in this group is taken to be 60%. Group two is the low residue diet group.

The primary hypothesis is that the incidence of postoperative ileus is not affected by the consistency of enteral diet given, and patients who are placed on low residue diet from postoperative day one do not have an increased risk of postoperative nausea and vomiting as compared to patients who are placed on clear feeds.

The primary endpoint measured is Patient tolerability, as evidenced by development of vomiting on postoperative day two.

Key Inclusion criteria are:

  1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
  2. Males or females, >18 years of age inclusive at the time of study screening;
  3. American Society of Anesthesiologists (ASA) Class I-III;
  4. Colorectal surgery (open and/or laparoscopic);
  5. Elective Surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
  • •Males or females, >18 years of age inclusive at the time of study screening;
  • •American Society of Anesthesiologists (ASA) Class I-III;
  • •Colorectal surgery (open and/or laparoscopic);
  • •Elective Surgery.

Exclusion Criteria

  • •Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures.
  • •Children <18 years of age.
  • •Pre-operative clinical diagnosis of intestinal obstruction.
  • •Pre-existing known upper gastrointestinal disorders.
  • •Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations.
  • •Open upper abdominal surgical incisions.
  • •Colorectal surgery with concomitant resectional surgery of the stomach or proximal jejunum (small bowel).
  • •Pregnant patients.
  • •Bedbound or moribund patients.
  • •Pre-existing history of clinical depression.
  • •Epidural analgesia.

Arms & Interventions

Low residue diet arm

Experimental

Two arm randomized controlled trial. First arm is the Clear feeds on postoperative day one arm.

The second arm (interventional arm) is the Low Residue diet on postoperative day one arm.

Intervention: Low Residue diet arm. (Dietary Supplement)

Clear feeds arm

Active Comparator

Standard of care is to start clear feeds on postoperative day one for elective colorectal surgery patients.

Intervention: Low Residue diet arm. (Dietary Supplement)

Outcomes

Primary Outcomes

Development of nausea and vomiting on postoperative day two

Time Frame: postoperative day two

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Phillip Fleshner MD

Program Director, Colorectal Surgery Fellowship Shierley, Jesslyne, and Emmeline Widjaja Chair in Colorectal Surgery

Cedars-Sinai Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Prospective Controlled Trial On Clear... | Clinical Trial